Concurrent chemoradiation treatment at high-volume facilities improves survival for NSCLC

Patients in the United States treated with definitive concurrent chemotherapy and radiotherapy for stage III non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers.

Medical Xpress